U.S., Dec. 7 -- ClinicalTrials.gov registry received information related to the study (NCT03758820) titled 'Behavior Cognitive Therapy on Fatigue Impact in MS Patients' on Oct. 19, 2017.

Brief Summary: Multiple sclerosis (MS) is a chronic inflammatory disease that leads to demyelination of the central nervous system. Fatigue is one of the most frequent and most disabling symptoms of MS. Up to 86% of individuals with MS experience fatigue at any one time; 65% consider it to be one of their three most troubling symptoms. Fatigue may limit or prevent participation in dayly activities and reduce psychological well-being (1, 2). Pharmacological and non-pharmacological treatments are available for MS-related fatigue, but evidence on effectivenes...